This observational study will follow patients requiring implantation of leadless pacemaker for 5 years after implantation. The main goal is to evaluate the long term safety and efficacy of AVEIR™ leadless pacemaker device in the usual clinical settings within the UK National Health Service. In addition, the study will collect data to understand patient characteristics receiving this type of pacemaker.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of patients without complications related to the device or implantation procedure.
Timeframe: 5 years
Percentage of patients requiring re-intervention.
Timeframe: 5 years
Stimulation threshold (V) in the therapeutic zone
Timeframe: 5 years
Percentage of stimulation in the therapeutic zone
Timeframe: 5 years
Impedance (Ohm) of R waves in the therapeutic zone
Timeframe: 5 years
Amplitudes of R waves (mV) in the therapeutic zone
Timeframe: 5 years